Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-T Meeting 2024 | The importance of a multidisciplinary team when treating autoimmune disease with CAR T-cell therapy

Raffaella Greco • 2 Feb 2024
CAR-T Meeting 2024
General Non-Malignant CAR-T

Raffaella Greco, MD, PhD, San Raffaele Hospital, Milan, Italy, discusses the development of the CAR T-cell therapeutic approach for the treatment of autoimmune disease, emphasizing the need for a multidisciplinary team throughout the entirety of the treatment process in these patients. This interview took place at the EBMT-EHA 6th European CAR T-cell Meeting in Valencia, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Raffaella Greco

2:55
CAR-T in the field of autoimmune disease
Raffaella Greco • 2 Feb 2024
1:47
A session exploring CAR-T in autoimmune disease at the CAR-T Meeting 2024
Raffaella Greco • 2 Feb 2024
0:59
The importance of the EBMT-EHA European CAR T-cell meeting 2024
Raffaella Greco • 2 Feb 2024
1:00
Addressing toxicity management after CAR-T therapy: an ongoing project of the EBMT & EHA
Raffaella Greco • 10 Feb 2023

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:01
The MDT in the new era of gene therapy for hemoglobinopathies
Mattia Algeri • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals